Reduction of infracardiac intestinal activity by a small amount of soda water in technetium-99m tetrofosmin myocardial perfusion scintigraphy with adenosine stress

J Nucl Cardiol. 2008 Mar-Apr;15(2):241-5. doi: 10.1016/j.nuclcard.2007.09.029. Epub 2008 Mar 6.

Abstract

Background: In technetium (Tc)-99m myocardial perfusion imaging (MPI), intestinal activity often interferes with the assessment of myocardial perfusion of the inferior wall. We examined whether a small amount of soda water prevents intestinal activity and improves image quality of the inferior wall in Tc-99m tetrofosmin MPI.

Methods and results: Ninety-five patients referred for 1-day rest/stress Tc-99m tetrofosmin MPI were assigned to one of two groups automatically, according to the date when they underwent MPI: the soda water group (n = 63) ingested 100 mL soda water just before image acquisition after adenosine stress, and the control group (n = 32) underwent no intervention. The frequency of intestinal activity was assessed visually on planar images. The inferior myocardial wall and the abdominal activity adjacent to the myocardium were assessed quantitatively on three different planar images during stress, and the mean inferior wall-to-abdomen (I/A) count ratio was calculated. The frequency of intestinal activity was 69.8% in the soda water group, and 90.6% in the control group (P = .038). The I/A count ratio was significantly higher in the soda water group than in the control group (1.98 +/- 0.51 vs 1.50 +/- 0.35, respectively, P < .0001, +/- SD).

Conclusions: The intake of 100 mL of soda water improves intestinal activity and improves the image quality of the inferior wall.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adenosine* / administration & dosage
  • Aged
  • Artifacts
  • Carbonated Beverages*
  • Drug Interactions
  • Female
  • Humans
  • Image Enhancement / methods
  • Intestinal Mucosa / metabolism*
  • Intestines / diagnostic imaging*
  • Intestines / drug effects
  • Male
  • Organophosphorus Compounds / pharmacokinetics*
  • Organotechnetium Compounds / pharmacokinetics*
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / metabolism*

Substances

  • Organophosphorus Compounds
  • Organotechnetium Compounds
  • Radiopharmaceuticals
  • technetium tc-99m tetrofosmin
  • Adenosine